Prenetics Global Ltd (PRE) community

PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 10/30

$16.51−0.21 (-1.26%)

Close on Nov 13, 2026Market cap $278.59MP/E –Yield –

Community

Notes and questions about Prenetics Global from other investors

No posts about PRE yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Prenetics Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on May 1, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRE.

Compare: PRE vs LFVN · PRE vs LAB · PRE vs ZYBT · PRE vs MTEX · PRE vs MRVI

Revenue growth479.8% · median -5.7%

Gross margin52.8% · median 63.1%

Operating margin-48.1% · median -22.2%

Net margin-40.8% · median 0.6%

Company	Revenue	Growth
MRVI	$213.00M	+10.7%
LFVN	$172.14M	-24.8%
MTEX	$103.07M	-6.6%
PRE	$92.39M	+479.8%
LAB	$84.60M	-4.8%
ZYBT	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 98
Auditor: Deloitte Touche Tohmatsu
SEC CIK: 1876431

Advertisement
300 × 250

See a number that looks wrong?